Teva Pharmaceutical Stock Analysis

TEVA -  USA Stock  

USD 8.51  0.13  1.50%

The current Teva Pharmaceutical price slip created some momentum for investors as it was traded today as low as 8.45 and as high as 8.72 per share. The company executives were unable to exploit market volatilities in December. However, diversifying your overall positions with Teva Pharmaceutical Industries can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.72. The current volatility is consistent with the ongoing market swings in December 2021 as well as with Teva Pharmaceutical unsystematic, company-specific events.
Additionally, take a look at World Market Map.

Teva Pharmaceutical Stock Analysis 

 
Refresh
The Teva Pharmaceutical stock analysis report makes it easy to digest most publicly released information about Teva Pharmaceutical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Teva Pharmaceutical Stock analysis module also helps to analyze the Teva Pharmaceutical price relationship with some important fundamental indicators such as market cap and management efficiency.

Teva Pharmaceutical Stock Analysis Notes

About 48.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.86. The entity next dividend is scheduled to be issued on the 27th of November 2017. The firm had 2:1 split on the 1st of July 2004. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States. To find out more about Teva Pharmaceutical Industries contact Carlo Notaristefani at 972 3 914 8213 or learn more at https://www.tevapharm.com.

Teva Pharmaceutical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Teva Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Teva Pharmaceutical Industries or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Teva Pharmaceutical generated a negative expected return over the last 90 days
Teva Pharmaceutical has high likelihood to experience some financial distress in the next 2 years
Latest headline from stocknews.com: JNJ 3 Pharmaceutical Stocks to Buy for the Long-Term - StockNews.com

Teva Pharmaceutical Upcoming and Recent Events

Earnings reports are used by Teva Pharmaceutical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Teva Pharmaceutical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report8th of May 2017
Next Earnings Report3rd of August 2017
Next Fiscal Quarter End31st of March 2017
Next Fiscal Year End12th of February 2018
Last Quarter Report31st of December 2016
Last Earning Announcement31st of March 2016

Teva Pharmaceutical Largest EPS Surprises

Earnings surprises can significantly impact Teva Pharmaceutical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2001-04-11
2001-03-310.10.110.0110 
2000-05-04
2000-03-310.070.080.0114 
1998-05-11
1998-03-310.060.05-0.0116 
View All Earnings Estimates

Teva Pharmaceutical Thematic Classifications

In addition to having Teva Pharmaceutical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Israel Wall Street IdeaIsrael Wall Street
Large Israel companies traded on major USA exchanges

Teva Pharmaceutical Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 10.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teva Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Teva Pharmaceutical Profitablity

Teva Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Teva Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Teva Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Teva Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Teva Pharmaceutical's profitability requires more research than a typical breakdown of Teva Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 4.47 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 17.81 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.18.

Management Efficiency

The entity has return on total asset (ROA) of 3.7 % which means that it generated profit of $3.7 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 6.99 %, meaning that it created $6.99 on every $100 dollars invested by stockholders. Teva Pharmaceutical management efficiency ratios could be used to measure how well teva pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 23rd of January, Teva Pharmaceutical has the coefficient of variation of (1,206), and Risk Adjusted Performance of (0.06). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teva Pharmaceutical, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Teva Pharmaceutical Industries, which can be compared to its competition. Please validate Teva Pharmaceutical information ratio, and the relationship between the downside deviation and value at risk to decide if Teva Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 8.51 per share. Given that Teva Pharmaceutical has jensen alpha of (0.17), we advise you to double-check Teva Pharmaceutical Industries's current market performance to make sure the company can sustain itself at a future point.

Teva Pharmaceutical Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Teva Pharmaceutical more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Teva Pharmaceutical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teva Pharmaceutical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teva Pharmaceutical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Teva Pharmaceutical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amir Weiss over a month ago via Macroaxis 
Teva Pharmaceutical exotic insider transaction detected
Tal Zaks over two months ago via Macroaxis 
Acquisition by Tal Zaks of 12205 shares of Teva Pharmaceutical subject to Rule 16b-3
Andrew Weil over two months ago via Macroaxis 
Acquisition by Andrew Weil of 29673 shares of Teva Pharmaceutical subject to Rule 16b-3
Schultz Kare over two months ago via Macroaxis 
Exercise or conversion by Schultz Kare of 180000 shares of Teva Pharmaceutical subject to Rule 16b-3
Gerald Lieberman over three months ago via Macroaxis 
Acquisition by Gerald Lieberman of 14479 shares of Teva Pharmaceutical subject to Rule 16b-3
Galia Inbar over three months ago via Macroaxis 
Teva Pharmaceutical exotic insider transaction detected
Hafrun Fridriksdottir over three months ago via Macroaxis 
Sale by Hafrun Fridriksdottir of 50860 shares of Teva Pharmaceutical
Ronit SatchiFainaro over six months ago via Macroaxis 
Exercise or conversion by Ronit SatchiFainaro of 12668 shares of Teva Pharmaceutical subject to Rule 16b-3
Eric Drape over six months ago via Macroaxis 
Exercise or conversion by Eric Drape of 37884 shares of Teva Pharmaceutical subject to Rule 16b-3
Mark Sabag over six months ago via Macroaxis 
Sale by Mark Sabag of 127244 shares of Teva Pharmaceutical
Eliyahu Kalif over six months ago via Macroaxis 
Acquisition by Eliyahu Kalif of 85551 shares of Teva Pharmaceutical subject to Rule 16b-3
Brendan OGrady over six months ago via Macroaxis 
Exercise or conversion by Brendan OGrady of 1166 shares of Teva Pharmaceutical subject to Rule 16b-3

Teva Pharmaceutical Outstanding Bonds

Teva Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teva Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teva Pharmaceutical bonds can be classified according to their maturity, which is the date when Teva Pharmaceutical Industries has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Teva Pharmaceutical Predictive Daily Indicators

Teva Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teva Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Teva Pharmaceutical Forecast Models

Teva Pharmaceutical time-series forecasting models is one of many Teva Pharmaceutical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teva Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Teva Pharmaceutical Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Teva Pharmaceutical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teva Pharmaceutical shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Teva Pharmaceutical. By using and applying Teva Pharmaceutical Stock analysis, traders can create a robust methodology for identifying Teva Pharmaceutical entry and exit points for their positions.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States.

Current Teva Pharmaceutical Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Teva Pharmaceutical analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Teva Pharmaceutical analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
45.54Hold13Odds
Teva Pharmaceutical Industries current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Teva Pharmaceutical analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Teva Pharmaceutical stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Teva Pharmaceutical, talking to its executives and customers, or listening to Teva Pharmaceutical conference calls.
Teva Pharmaceutical Analyst Advice Details

Teva Pharmaceutical Stock Analysis Indicators

Teva Pharmaceutical Industries stock analysis indicators help investors evaluate how Teva Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Teva Pharmaceutical shares will generate the highest return on investment. By understating and applying Teva Pharmaceutical stock analysis, traders can identify Teva Pharmaceutical position entry and exit signals to maximize returns.
Quick Ratio0.51
Fifty Two Week Low7.73
Revenue Growth-2.30%
Shares Short Prior Month19.59M
Average Daily Volume Last 10 Day9.04M
Average Daily Volume In Three Month10.36M
Shares Percent Shares Out1.82%
Gross Margins46.78%
Forward Price Earnings3.49
Float Shares1.1B
Fifty Two Week High13.30
Enterprise Value To Ebitda7.53
Fifty Day Average8.65
Two Hundred Day Average9.60
Enterprise Value To Revenue1.99
Additionally, take a look at World Market Map. Note that the Teva Pharmaceutical information on this page should be used as a complementary analysis to other Teva Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Teva Pharmaceutical Stock analysis

When running Teva Pharmaceutical price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Teva Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharmaceutical. If investors know Teva Pharmaceutical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Teva Pharmaceutical is measured differently than its book value, which is the value of Teva Pharmaceutical that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharmaceutical's market value can be influenced by many factors that don't directly affect Teva Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Teva Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.